“Drugs companies publish only a fraction of their results and keep much of the information to themselves, but regulators want to ban the practice. If companies published all of their clinical trials data, independent scientists could reanalyse their results and check companies’ claims about the safety and efficacy of drugs. Under proposals being thrashed out in Europe, drugs companies would be compelled to release all of their data, including results that show drugs do not work or cause dangerous side-effects. The latest strategy shows how patient groups – many of which receive some or all of their funding from drugs companies – have been brought into the battle.”
Related posts:
European Union delays carbon tax for one year
McDonald's want ad demands bachelor's degree, two years experience for cashier
Canada to end airstrikes in Syria and Iraq: new prime minister Trudeau
Snowden Gets Whistleblower Award in Germany
Jim Rogers: Gold Mining Stocks Face Two Major Headwinds
China's new $16bn gold fund at centre of new 'Silk Road'
Trump's visa ban also applies to dual citizens
New Zealand Government Announces That Software Will No Longer Be Patentable
Absent Chavez devalues Venezuelan currency to aid gov't finances
U.S. Treasury cautions Bitcoin businesses on legal duties
Most people expect to be worse off than parents – except U.S., Chinese
NYPD faces class-action lawsuit over controversial stop-and-frisk policy
Silicon Valley can’t keep up with Korea’s financial revolution
Economists warn Cyprus will face a recession ‘for decades’ after EU deposit tax
The Company Making Billions Off China’s Worried Parents